Cynvenio Biosystems' Grant

Cynvenio Biosystems raised a round of funding on February 07, 2012. Investors include National Cancer Institute.

Cynvenio Biosystems, formerly CytomX, is focused on the development of the LiquidBiopsy platform, a high performance rare cell isolation technology for biomedical research and cancer diagnostics. Liqu…

Articles about Cynvenio Biosystems' Grant: